Kobayashi Pharmaceutical faces huge compensation as health food industry stalls and consumer spending continues to slow down – Mainichi Shimbun
小林製薬、迫られる多額補償 健康食品業界も失速、進む買え控え – 毎 日新聞
社を挙げて新商品開発に取り組み、外国人観光客の人気も集め、連結最 終 … 死者は5人、入院者は延べ200人を超える。医薬品には健康被害を救済する公 的制度が…
https://mainichi.jp/articles/20240421/k00/00m/040/097000c
Kobayashi Pharmaceutical faces huge compensation as health food industry stalls and consumer spending continues to slow down – Mainichi Shimbun
The company made a concerted effort to develop new products, and gained popularity with foreign tourists, resulting in a total of 5 deaths and over 200 hospitalizations. There is a public system for medicines that provides relief for health damage. …
*Translated using Google’s automatic translation function. If there are any mistranslations, please contact us.
Comments